NCT00097435View on ClinicalTrials.gov

A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Hepatitis C
Interventions
DRUG

Albuferon

DRUG

Ribavirin

Trial Locations (8)

21287

Johns Hopkins University, Baltimore

22031

Metropolitan Research, Fairfax

27710

Duke University, Durham

32209

University of Florida at Jacksonville, Jacksonville

32216

Mayo Clinic Jacksonville, Jacksonville

32610

University of Florida CRC, Gainesville

55905

Mayo Clinic Rochester, Rochester

85054

Mayo Clinic, Phoenix

Sponsors
All Listed Sponsors
lead

Human Genome Sciences Inc.

INDUSTRY